PLUS1
Best deals to access real time data! |
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
CHART Trader
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Castle Biosciences Inc | CSTL | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| -0.46 | -2.34% | 19.21 | 19.71 | 19.21 | 19.71 | 19.67 | 10:00:08 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 18.88 | 19.55 | 0.67 | 3.43% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 29 | 2,622 | $ 19.61 | $ 51,410 | 134,670 | 16.78 - 28.50 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 09:59:38 | 12 | $ 19.03 | USD |
Castle Biosciences Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 327.90M | 17.07M | $ 669.00k | -0.62 | -225.56 | 15.10M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | 19.00 | 11.50% |
Castle Biosciences News
| Date | Time | Source | News Article |
|---|---|---|---|
| 10/07/2019 | 07:00 | Business Wire | Newly Published Systematic Review Confirms Strength of.. |
| 9/19/2019 | 07:00 | Business Wire | Castle Biosciences Added to Membership of US Small-Cap.. |
| 9/03/2019 | 19:56 | Business Wire | Castle Biosciences Announces Time Change for Presentation at.. |
| 9/03/2019 | 16:05 | Business Wire | Castle Biosciences Reports Second Quarter 2019 Results |
| 8/27/2019 | 07:00 | Business Wire | Castle Biosciences to Present at the Baird 2019 Global.. |
| 8/22/2019 | 07:00 | Business Wire | Castle Biosciences to Release Second Quarter 2019 Financial.. |
| 7/29/2019 | 17:42 | Business Wire | Castle Biosciences Announces Closing of Initial Public.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CSTL Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol [m] | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 19.07 | 20.11 | 17.79 | 19.4781 | 78k | 0.14 | 0.73% |
| 1 Month | 21.66 | 24.16 | 16.78 | 20.5740 | 134k | -2.45 | -11.31% |
| 3 Months | 20 | 28.5 | 16.78 | 21.9040 | 165k | -0.79 | -3.95% |
| 6 Months | 20 | 28.5 | 16.78 | 21.9040 | 165k | -0.79 | -3.95% |
| 1 Year | 20 | 28.5 | 16.78 | 21.9040 | 165k | -0.79 | -3.95% |
| 3 Years | 20 | 28.5 | 16.78 | 21.9040 | 165k | -0.79 | -3.95% |
| 5 Years | 20 | 28.5 | 16.78 | 21.9040 | 165k | -0.79 | -3.95% |
Castle Biosciences Description
| Castle Biosciences Inc is a United States-based company engaged in developing and commercializing diagnosis and prognostic tests for dermatologic cancers. Its non-invasive products utilize algorithms to provide an assessment of a patient's specific risk of metastasis or recurrence of their cancer. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME among others. |
